Ragaglitazar is a PPARalpha and PPARgamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic.
Molecular Weight:
419.47
Purity:
99.24
CAS Number:
[222834-30-2]
Formula:
C25H25NO5
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted